| Nov 14 |
NervGen Pharma Reports Q3 2024 Financial Results and Operational Updates
|
| Nov 7 |
NervGen Pharma to Present at the Stifel 2024 Healthcare Conference
|
| Aug 27 |
NervGen Pharma to Present at the H.C. Wainwright 26th Annual Global Investment Conference
|
| Aug 18 |
Here's Why We're Not At All Concerned With NervGen Pharma's (CVE:NGEN) Cash Burn Situation
|
| Aug 6 |
NervGen Pharma to Present at the Canaccord Genuity 44th Annual Growth Conference
|
| Jun 25 |
NervGen Pharma to Advance NVG-300 into Preclinical Proof-of-Concept Stage
|
| Jun 20 |
NervGen Pharma to Present at the 2nd Annual Spinal Cord Injury Investor Symposium
|
| Jun 6 |
NervGen Pharma Grants Stock Options
|
| Jun 5 |
NervGen Pharma Announces Results of Annual General Meeting of Shareholders
|
